Our dCELL® technology is derived from the natural structural tissue to be replaced in the body. The dCELL® process ensures the biomechanical structure and function of the donor tissue is retained as far as possible.
The devices could be able to attract and support tissue regeneration within their existing physical and biochemical architecture.
The creation of the dCELL® technology uses low concentration SDS and proteinase inhibitors to preserve tissue structure – this is in marked contrast to other products that use high concentration of reagents that may destroy the tissue structure.
Our dCELL® technology is derived from the natural structural tissue to be replaced in the body and retains its biomechanical structure and function by in the short and longer term.
The devices are able to attract and support tissue regeneration within the existing physical and biochemical architecture.
The creation of the dCELL® technology uses a low concentration SDS & proteinase inhibitors to preserves tissue structure – this is in marked contrast to other products that use high concentrations of reagents that destroy the tissue structure. Likewise, the devices do not require chemical fixatives, whereas others treat acellular biological scaffolds with fixatives which prevent cells migration.
dCELL® human dermis patches may allow a better chance of healing for chronic wounds (including ulcers and burns) and potentially faster healing for acute wounds (including surgical incisions and traumatic injuries).
dCELL® heart valves replace the patient’s own damaged valves, and may provide a biological scaffold for population by patient's own cells.
dCELL® decellularises porcine meniscus for implanting into the patient’s knees as a matrix to attract stem-cells and allow natural healing of damaged joints.
dCELL® vascular patches can be used in vascular surgery to provide effective closure with evidence of integration with patient’s own vessel.
Sign up to our mailing list to keep up with the latest news and developments from Tissue Regenix.
View alerts sign-up page
© Tissue Regenix Group plc 2017
Most computers will open PDF documents automatically, but you may need to download Adobe Reader.